Vamifeport
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.
Product Specifications
CAS Number
2095668-10-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
408.43
Molecular Formula
C21H21FN6O2
Notes
Research use only, not for human use.
Receptor
Ferroptosis
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6331307-01 0.2 mL
PCAF, NT (KAT2B, PCAF, Histone acetyltransferase KAT2B, Histone acetyltransferase PCAF, Lysine acetyltransferase 2B, P300/CBP-associated factor) (PE)
Ask
View Details MBS6331307-02 5x 0.2 mL
PCAF, NT (KAT2B, PCAF, Histone acetyltransferase KAT2B, Histone acetyltransferase PCAF, Lysine acetyltransferase 2B, P300/CBP-associated factor) (PE)
Ask
View Details NBP3-18116MFV500 0.1 mL
Mouse Monoclonal CXCL11/I-TAC Antibody (B-K43) [mFluor Violet 500 SE]
Ask
View Details 
GTR15196613 1 Vial
Lentiviral mouse Satb1 shRNA (UAS) - Lentiviral mouse Satb1 shRNA (UAS) (25)
Ask
View Details